Shypd.aiThe largest open index of AI toolsArtera is an AI-powered precision medicine tool that transforms cancer therapy through innovation. It provides personalized insights for prostate and breast cancer treatment by analyzing digital pathology and clinical data.
Trending
About
Artera is a leading AI-powered precision medicine platform focused on transforming cancer therapy. Utilizing a multi-modal artificial intelligence (MMAI) platform, Artera analyzes digital pathology and clinical data to provide personalized cancer management insights. The ArteraAI Prostate Test, which has received FDA De Novo Authorization, offers therapeutic insights for early-stage prostate cancer and predicts which NCCN Intermediate-risk patients benefit from ST-ADT with radiation therapy. It is the first and only AI test recommended in the NCCN Clinical Practice Guidelines in Oncology for Prostate Cancer. Additionally, the ArteraAI Breast Cancer Test provides 5- and 10-year distant metastasis risk for early-stage breast cancer patients and predicts chemotherapy benefit for node-negative patients 50 years or older. The platform is validated in numerous large, randomized phase III clinical trials and offers rapid turnaround times for results.
Capabilities
Pricing & Plans
Likely Not Free
Contact for Pricing
FAQs
Trending
.png&w=3840&q=75){kind=small}